Skip to main content

Table 7 Characteristics of 14 locally advanced patients without resection

From: Neoadjuvant chemotherapy followed by curative-intent surgery for perihilar cholangiocarcinoma based on its anatomical resectability classification and lymph node status

No

Age

(years)

Gender

Factor of unresectability

Chemo-therapy

Radio-therapy

Reason of death

Survival

(status)

1)

50’s

M

Vascular (PV and HA)**

GS

50.4Gy

Local tumor growth

92.0 m (Dead)

2)

80’s

M

Biliary* + Vascular (PV and HA)**

GS

36Gy

Other disease

14.7 m (Dead)

3)

80’s

F

Biliary* + Vascular (HA)**

–

–

Local tumor growth

3.1 m (Dead)

4)

70’s

M

Biliary* + Vascular (HA)**

GS

–

Dissemination

Liver metastasis

13.9 m (Dead)

5)

70’s

M

Vascular (HA)**

GS

–

Local tumor growth

Liver metastasis

21.6 m (Dead)

6)

60’s

M

Biliary* + Vascular (HA)**

GS → GC

–

Local tumor growth

Lung metastasis

18.5 m (Dead)

7)

60’s

M

Biliary*

GS

–

Local tumor growth

Dissemination

18.3 m (Dead)

8)

70’s

M

Biliary*

GS → GC

36Gy

Local tumor growth, Dissemination

16.7 m (Dead)

9)

70’s

M

Vascular (HA)**

–

–

Local tumor growth, Dissemination

10.9 m (Dead)

10)

60’s

F

Biliary*

GS → GC

–

Local tumor growth

Liver and bone metastasis

16.7 m (Dead)

11)

40’s

F

Vascular (PV and HA)**

GS → GC

–

Local tumor growth

Distant LN metastasis

17.2 m (Dead)

12)

50’s

M

Vascular (PV and HA)**

G → GC

45Gy

Dissemination

Lung and bone metastasis

24.0 m (Dead)

13)

70’s

M

Vascular (HA)**

GS → GC

–

–

18.0 m (Alive)

14)

80’s

M

Vascular (HA)**

GS

–

–

5.1 m (Alive)

  1. *Biliary factor: biliary margin negative could not be obtained by either side of right or left trisectionectomy
  2. **Vascular factor: Unreconstructible HA and/or PV due to tumor involvement or occlusion
  3. G gemcitabine, GS gemcitabine + TS-1, GC gemcitabine + cisplatin